期刊文献+

中晚期肿瘤患者护理者对姑息支持和临终关怀的选择倾向 被引量:10

The Preference of Palliative Care and Hospice in Caregivers for Patients with Advanced Cancer
原文传递
导出
摘要 [目的]了解中晚期肿瘤患者的主要护理者对姑息支持和临终关怀的选择倾向。[方法]采用调查问卷法对141位中晚期恶性肿瘤患者的主要护理者进行调查。[结果]接受调查的护理者在选择医疗方案时,选择率最高的依次为,第1位考虑因素为生存期延长时间,选择率70.2%;第2位为肿块缩小程度,选择率39.0%;第3位为副作用大小,选择率51.1%;第4位为经济压力大小,选择率63.8%。对应停止积极攻击性的治疗而改予临终关怀的病例,仅46.1%的护理者第一反应认为应该选择姑息支持和临终关怀方案;在给出7方面24种细节性影响因素后,选择率全部发生变化,其中22项选择率明显上升,仅2项下降。对于极优组合(副作用小+肿块缩小+生存期延长+经济压力小)和极劣组合(副作用大+肿块变大+生存期缩短+经济压力大),选择率分别是95.0%和1.4%,基本符合"理性选择原则";但对"非极优极劣"组合,方案可接受条件中生存期延长时间期望值均为2年或2年以上;对于"副作用大+肿块变大+生存期延长"这样存在可能性很小的两个组合,选择率达到1/4~1/3。[结论]中晚期肿瘤患者护理者因照顾患者产生的问题较多,对于一般医疗方案选择时首要考虑生存期延长时间,结果比过程更重要。对治疗期望值高,部分护理者延长患者生命意愿强烈。对于姑息支持和临终关怀方案,第一反应选择率低,考虑到复杂因素后接受度普遍提高,个别下降,影响因素较多。
出处 《中国肿瘤》 CAS 2011年第11期825-829,共5页 China Cancer
  • 相关文献

参考文献5

  • 1周天,张培彤.晚期肺癌患者选择姑息支持和临终关怀的影响因素[J].中国肿瘤,2010,19(2):125-130. 被引量:8
  • 2Hillner BE, Smith TJ. Efficacy does not necessarily translate to cost effec- tiveness: a case study in the challenges associated with 21st-century cancer drug pricing [J]. J Clin Oncol, 2009, 27(13): 2111-2113.
  • 3Peppercorn JM, Smith TJ, Helft PR, et al. American Society of Clinical On- cology statement: toward individualized care for patients with advanced cancer [J]. J Clin Oncol, 2011, 29(6): 755-760.
  • 4Smith TJ, Hillner BE. Bending the cost curve in cancer care [J]. N Engl J Med, 2011, 364(21): 2060-2065.
  • 5Zhang B, Wright AA, Huskamp HA, et al. Health care costs in the last week of life: associations with end-of-life conversations[J]. Arch Intern Med, 2009, 169(5): 480-488.

二级参考文献26

  • 1孙燕,石远凯.临床肿瘤内科手册[M].第5版.北京:人民卫生出版社,2008:482
  • 2Free CM, Ellis M, Beggs L, et al. Lung cancer outcomes at a UK cancer unit between 1998-2001 [J]. Lung Cancer, 2007, 57 (2): 222-228.
  • 3Gilbert CR, Smith CM. Advanced lung disease: quality of life and role of palliative care [J]. Mt Sinai J Med, 2009, 76(1):63-70.
  • 4Lidstone V, Butters E, Seed PT, et al. Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care [J].Palliat Med, 2003, 17 (7): 588-595.
  • 5Youlden DR, Cramb SM, Baade PD. The International epidemiology of lung cancer: geographical distribution and secular trends [J]. Thorac Oncol, 2008, 3 (8): 819-831.
  • 6Novello S, Vavala T. Lung cancer and women [J].Future Oncol, 2008,4(5):705-716.
  • 7Siminoff LA, Rose JH, Zhang A, et al. Measuring discord in treatment decision-making: progress toward development of a cancer communication and decision-making assessment tool [J]. Psychooncology, 2006, 15(6): 528-540.
  • 8Zhang AY, Siminoff LA. The role of the family in treatment decision making by patients with cancer [J]. Oncol Nuts Forum, 2003, 30 (6):1022-1028.
  • 9Temel JS, McCannon J, Greer JA, et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC [J]. Cancer, 2008, 113(4): 826-833.
  • 10Morita T, Shima Y, Miyashita M, et al. Physician and nurse-reported effects of intravenous hydration therapy on symptoms of temlinally Ⅲ patients with cancer [J]. palliat Med, 2004, 7(5):683-693.

共引文献7

同被引文献73

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部